NCT05105711

Mobile Coaching to Improve HPV Vaccine Delivery

Completed NA Results posted Last updated 25 July 2022

What this trial tests

NA trial testing QI coaching intervention in HPV Vaccine in 21 participants. Completed in 14 January 2022.

Timeline

21 June 2021

Primary endpoint
14 January 2022

14 January 2022

Quick facts

Lead sponsor	UNC Lineberger Comprehensive Cancer Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	health services research
Enrollment	21
Start date	21 June 2021
Primary completion	14 January 2022
Estimated completion	14 January 2022
Sites	1 location across United States

Drugs / interventions tested

• QI coaching intervention

Conditions studied

• HPV Vaccine — all drugs for HPV Vaccine →
• Provider Communication Practices — all drugs for Provider Communication Practices →
• Vaccine Recommendation Practices — all drugs for Vaccine Recommendation Practices →

Sponsor

UNC Lineberger Comprehensive Cancer Center — full company profile →

Who can join

18 and older, any sex, with HPV Vaccine or Provider Communication Practices. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Change in HPV Vaccine Recommendation Quality Score Primary · Baseline, 12 weeks

The change in providers' mean composite score on a 5-item index of self-reported use of HPV vaccine communication practices with scores ranging from 5-25 (5 indicating the lowest quality score to 25 indicating the highest quality score).

Baseline

Group	Value	95% CI
Primary Care Providers	23.4	18 – 25

Follow-up

Group	Value	95% CI
Primary Care Providers	24.2	17 – 25

Sponsor's own description

The purpose of this study is to examine the feasibility of using Checkup Coach, a mobile coaching intervention, to improve the way that primary care providers recommend HPV vaccination to adolescent patients and their parents. To conduct this feasibility study, the investigators will deliver the Checkup Coach intervention to 20 Kaiser Permanente Washington primary care providers who routinely recommend HPV vaccine to adolescent patients. The investigators will use a single-arm, pre-post design. Participating primary care providers will attend a 1-hour virtual communication workshop and then use a mobile phone app to receive additional coaching for 12 weeks. Providers will complete surveys at three time points: before the communication workshop, immediately after the workshop, and at 12-week follow-up. Surveys will assess changes in providers' self-reported HPV vaccine recommendation practices and beliefs about HPV vaccine and also acceptability of the intervention. The investigators hypothesizes that providers' HPV vaccine communication will improve between baseline and 12-week follow-up.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Feasibility of using an app-based coaching intervention to improve provider communication about HPV vaccination.
   Grabert BK, McRee AL, Henrikson NB, Heisler-MacKinnon J, et al · · 2023 · cited 3× · PMID 36999806 · DOI 10.1093/tbm/ibad002